Harbor Capital Advisors’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12K Sell
128
-3
-2% -$254 ﹤0.01% 960
2026
Q1
$11K Sell
131
-17,613
-99% -$1.45M ﹤0.01% 952
2025
Q4
$1.63M Buy
17,744
+1,723
+11% +$165K 0.13% 225
2025
Q3
$1.52M Sell
16,021
-32,610
-67% -$3.07M 0.12% 232
2025
Q2
$5.09M Buy
48,631
+9,701
+25% +$920K 0.21% 153
2025
Q1
$3.44M Buy
38,930
+38,885
+86,411% +$3.99M 0.16% 203
2024
Q4
$4K Sell
45
-1
-2% -$93 ﹤0.01% 1182
2024
Q3
$4K Buy
+46
New +$3.55K ﹤0.01% 1164

Other funds holding HQY

Harbor Capital Advisors's HQY Position: Q2 2026 in Review

Harbor Capital Advisors reduced its HealthEquity (HQY) stake by 2.3% in Q2 2026, selling an estimated $254 and leaving 128 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #960.

Harbor Capital Advisors first reported a position in HQY in Q3 2024 and has held it in 8 quarters since. The position peaked at $5.09M in Q2 2025. 501 funds tracked by Wall St. Rank hold HQY as of Q2 2026.

  • Harbor Capital Advisors held 128 shares of HealthEquity worth $12K as of Q2 2026.
  • Harbor Capital Advisors sold 3 HealthEquity shares in Q2 2026, an estimated $254.
  • HealthEquity made up ﹤0.01% of Harbor Capital Advisors's portfolio in Q2 2026, its #960 holding.
  • Harbor Capital Advisors first reported a position in HealthEquity in Q3 2024 and has held it in 8 quarters since.
  • Harbor Capital Advisors's HealthEquity position peaked at $5.09M in Q2 2025.
  • 501 funds tracked by Wall St. Rank held HealthEquity as of Q2 2026.

Based on Harbor Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.